MarketPeel
Insider Trading Intelligence
DS

Dean L. Schorno

RIGL
EVP &CHIEF FINANCIAL OFFICER · RIGEL PHARMACEUTICALS INC · CIK 0001509688
FILING MIX · LIFETIME69%/31%
BUYS
29
SELLS
13
TOTAL VALUE
$641.9K
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
7,394
AVG SELL PX
$14.24
TRADE KIND
SHOWING 42 / 42
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
4 backtested trades · 8 horizons · 2 pendingHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by Dean L. Schorno, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d4+50.00%-0.07%+0.89%-0.95%+0.51%
14d4+75.00%-2.56%+1.24%-3.79%-2.80%
30d4+50.00%+11.64%-0.60%+12.24%+12.29%
60d4+50.00%-3.96%-5.30%+1.34%+1.55%
90d4+50.00%-5.82%-1.41%-4.41%-1.96%
180d4+75.00%-4.09%+7.75%-11.83%-12.42%
1y4+0.00%+70.30%+18.48%+51.82%+53.86%
2y4(2 pending)+0.00%+207.30%+42.21%+165.08%+165.08%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
RIGL · 7,394 shares · as of Jun 17, 2026
0103,880207,760311,639415,519202120222023202420252026SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
2021
2021
2022
2022
2022
2022
2023
2023
2023
2023
2024
2024
2024
2024
2025
2025
2025
2025
2026
2026
FLOW · 29 buys / 13 sellsCOVERAGE · 26 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
7,3947,394Jun 17, 2026Jun 22, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP & Chief Financial Officer
2,18113,518Jun 1, 2026Jun 3, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASE
EVP & Chief Financial Officer
2,181$12.70$27.7K79,718Jun 1, 2026Jun 3, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP & Chief Financial Officer
1,2009,632Jun 1, 2026Jun 3, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASE
EVP & Chief Financial Officer
1,200$18.70$22.4K77,537Jun 1, 2026Jun 3, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP & Chief Financial Officer
928$29.86$27.7K78,790Jun 1, 2026Jun 3, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
20,63676,337Feb 17, 2026Feb 19, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP & Chief Financial Officer
3,546$34.62$122.8K55,701Feb 10, 2026Feb 12, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP & Chief Financial Officer
5,488$36.01$197.6K59,247Feb 2, 2026Feb 4, 2026View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASE
EVP & Chief Financial Officer
1,987$20.00$39.7K59,722Dec 22, 2025Dec 29, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP & Chief Financial Officer
1,66710,832Dec 22, 2025Dec 29, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASE
EVP & Chief Financial Officer
1,667$18.70$31.2K64,235Dec 22, 2025Dec 29, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP & Chief Financial Officer
2,84617,153Dec 22, 2025Dec 29, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP & Chief Financial Officer
1,98714,262Dec 22, 2025Dec 29, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASE
EVP & Chief Financial Officer
2,846$24.20$68.9K62,568Dec 22, 2025Dec 29, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
7,3947,394Sep 15, 2025Sep 17, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
7,8507,850Mar 17, 2025Mar 19, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
5,6255,625Mar 17, 2025Mar 19, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP & Chief Financial Officer
1,734$21.93$38.0K57,235Feb 5, 2025Feb 6, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP & Chief Financial Officer
2,036$20.92$42.6K58,969Feb 4, 2025Feb 6, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
14,78814,788Jan 29, 2025Jan 31, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
19,71761,005Jan 29, 2025Jan 31, 2025View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
6,2506,250Nov 25, 2024Nov 26, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
10,00010,000Aug 30, 2024Sep 4, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
78,50078,500Feb 28, 2024Mar 1, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
62,50062,500Feb 28, 2024Mar 1, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP & Chief Financial Officer
7,027$1.14$8.0K402,891Feb 5, 2024Feb 6, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP & Chief Financial Officer
5,601$1.13$6.3K409,918Feb 2, 2024Feb 6, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
157,000157,000Jan 23, 2024Jan 25, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
209,000415,519Jan 23, 2024Jan 25, 2024View →
RIGL
RIGEL PHARMACEUTICALS INC
SALE
EVP & Chief Financial Officer
5,389$1.66$8.9K196,519Feb 2, 2023Feb 6, 2023View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
63,000201,908Jan 26, 2023Jan 30, 2023View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
125,000125,000Jan 26, 2023Jan 30, 2023View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
50,000100,000Jan 26, 2023Jan 30, 2023View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
50,00050,000Dec 28, 2022Dec 30, 2022View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
81,25081,250Sep 14, 2022Sep 16, 2022View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
100,000100,000Jan 24, 2022Jan 26, 2022View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
50,000128,908Jan 24, 2022Jan 26, 2022View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
81,25081,250Nov 4, 2021Nov 5, 2021View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
50,00050,000Apr 1, 2021Apr 2, 2021View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
112,500112,500Jan 27, 2021Jan 28, 2021View →
RIGL
RIGEL PHARMACEUTICALS INC
PURCHASEGRANT
Stock grant
200,000200,000Feb 6, 2020Feb 7, 2020View →
Other insiders · RIGL
Loading peer insiders…
About this filer
CIK 0001509688
ROLE
EVP &Chief Financial Officer
PRIMARY
RIGL
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001509688DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback